Cargando…
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
BACKGROUND: Reliable biomarkers of frontotemporal dementia (FTD) are currently lacking. FTD may be associated with chronic immune dysfunction, microglial activation and raised inflammatory markers, particularly in progranulin (GRN) mutation carriers. Levels of soluble triggering receptor expressed o...
Autores principales: | Woollacott, Ione O. C., Nicholas, Jennifer M., Heslegrave, Amanda, Heller, Carolin, Foiani, Martha S., Dick, Katrina M., Russell, Lucy L., Paterson, Ross W., Keshavan, Ashvini, Fox, Nick C., Warren, Jason D., Schott, Jonathan M., Zetterberg, Henrik, Rohrer, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094471/ https://www.ncbi.nlm.nih.gov/pubmed/30111356 http://dx.doi.org/10.1186/s13195-018-0405-8 |
Ejemplares similares
-
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019) -
CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019) -
Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018) -
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016) -
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
por: Banerjee, Gargi, et al.
Publicado: (2021)